Results 81 to 90 of about 149,549 (197)
Nanoemulsion delivery of a TLR7 agonist enhances safety and promotes colocalization with Leishmania‐infected macrophages in skin lesions, enabling a ∼2‐log reduction in parasite burden. However, tissue‐level constraints and TLR‐driven regulatory feedback generate a mixed immune response that limits complete parasite clearance.
Carmen Palomino‐Cano +11 more
wiley +1 more source
Background: Recently, with better understanding of the immunology of warts, immunotherapeutic approaches have emerged as an effective treatment option for the management of cutaneous warts.
Chesta Agrawal +4 more
doaj +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katja Schabet +3 more
wiley +1 more source
Candida Albicans versus Candida Tropicalis Antigens in Treatment of Recalcitrant Wart [PDF]
Background: Recalcitrant warts often require immune-based therapies, with Candida albicans antigen being the most used modality. Little is known about the clinical performance of Candida tropicalis as an alternative antigen despite biological ...
Amin Amer +3 more
doaj +1 more source
ABSTRACT Introduction Alopecia areata is a long‐term autoimmune disease that causes hair loss in approximately 2% of people but does not result in permanent scarring. Intralesional corticosteroid treatment provides effective results; however, long‐term use may lead to skin atrophy and telangiectasia.
Ramazan Ülker +2 more
wiley +1 more source
Measles, mumps and rubella vaccine as an intralesional immunotherapy in treatment of warts [PDF]
Background: To observe the efficacy and safety of intralesional Measles Mumps and Rubella (MMR) vaccine in the treatment of warts.Methods: 50 patients with single or multiple warts more than 06 months duration in all age groups were included in the study.
Patel, Dhara +2 more
core +1 more source
Updates on intratumoral therapies in melanoma
Abstract Intratumoral therapies provide an opportunity for novel strategies in the management of advanced melanoma. These approaches deliver concentrated doses of therapeutic immune agents directly into individual tumor(s), achieving local tumor control and induction of systemic antitumor immune responses while minimizing the risk of immune‐related ...
Vincent T. Ma +12 more
wiley +1 more source
Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.
Immunotherapy is an evolving therapeutic modality for the treatment of warts. We conducted a study to assess the efficacy and safety of intralesional Mycobacterium w vaccine for the treatment of warts at sites that were difficult to treat.Thirty patients with at least one wart present on either the plantar surface of their feet, palms, volar aspect of ...
Garg S, Baveja S.
europepmc +3 more sources
Systemic Immunosuppression to Reduce Surgical Intervention in ANCA‐Negative Subglottic Stenosis
Idiopathic subglottic stenosis (iSGS) typically follows an indolent course managed with surgical dilatation, though a subset demonstrates aggressive, recurrent disease. In this retrospective cohort study, systemic immunosuppression significantly prolonged inter‐dilation intervals in both granulomatosis with polyangiitis‐associated SGS and an “atypical”
Guy Benshetrit +5 more
wiley +1 more source
Intralesional Talimogene Laherparepvec Immunotherapy for Melanoma: A Case Study
Melanoma, characterized by its aggressive nature and tendency for metastasis, presents a significant challenge in clinical management. While surgical excision remains the gold standard for localized disease, therapeutic advancements for advanced stages are crucial.
Ghebrehiwet, Merhawit +2 more
openaire +2 more sources

